Alligator Bioscience Select Sartorius Stedim Cellca as Cell Line Development Partner

Following the news release from Alligator Bioscience on 12th June 2017, Sartorius Stedim Cellca GmbH is delighted to partner with the innovative Swedish biotech company, Alligator Bioscience to support the pre-clinical development of their 4-1BB immuno-oncology antibody ATOR-1017. ATOR-1017 is an agonistic antibody that activates the co-stimulatory receptor 4-1BB (also known as CD137) expressed on More

Cell Line Development Services

Download our slides to find out more about our cell line development services and the Cellca CHO Expression Platform.

Sartorius Stedim Biotech Launches Chemistry Testing Services

Goettingen, GER | Glasgow, UK – May 4, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have More

Sartorius Stedim BioOutsource Scoop Life Science Company of the Year Award

On Wednesday 19th April 2017, Sartorius Stedim BioOutsource was named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More

Biosimilars: Lessons Learned

A Quality by Design approach to de-risk biosimilar development Learn more about the evolving biosimilar development pathway and how a QbD approach ensures a step-wise, orthogonal process to de-risk development and improve speed to market. Watch on demand now

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.